Literature DB >> 10609204

Phototherapeutic keratectomy for treatment of recurrent corneal erosion.

S Jain1, D J Austin.   

Abstract

PURPOSE: To study the role of phototherapeutic keratectomy (PTK) in the management of recurrent corneal erosion (RCE) refractory to other forms of treatment.
SETTING: The Eye Department of Leicester Royal Infirmary, a tertiary referral center, Leicester, England.
METHOD: A retrospective analysis of all patients who had PTK for refractory RCE between July 1994 and October 1998 was performed. The patients were recalled to determine whether they had further symptoms and whether there had been a change in their refractive error or their best corrected visual acuity.
RESULTS: Seventy-seven eyes of 68 patients were treated and divided into 3 etiologic groups: trauma, 40 eyes; corneal dystrophy, 24 eyes; and no established cause (idiopathic), 13 eyes. Phototherapeutic keratectomy was combined with photorefractive keratectomy (PRK) in 6 eyes with a good result. A single treatment was performed in 71 eyes (92.2%). No significant refractive change occurred in 67.5% of eyes; 22.1% developed hyperopia (range 0 to +2.0 diopters [D]), and 10.3% developed myopia (range 0 to -1.5 D). Best corrected visual acuity was unchanged in 72.7% of eyes; 11.7% lost 1 Snellen line and 15.5% gained 1 line. There were no symptoms in 68.8% of eyes; in 31.2%, minor symptoms were noted in the morning, and these patients continued to use ocular lubricants at night.
CONCLUSION: Phototherapeutic keratectomy is a safe and effective treatment for refractory RCE and, where appropriate, can be combined with PRK.

Entities:  

Mesh:

Year:  1999        PMID: 10609204     DOI: 10.1016/s0886-3350(99)00262-x

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  8 in total

1.  Phototherapeutic keratectomy re-treatment for recurrent corneal erosion syndrome.

Authors:  R Maini; M S Loughnan
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

2.  Phototherapeutic keratectomy (PTK) for treatment of recurrent corneal erosion: Correlation between etiology and prognosis - prospective longitudinal study.

Authors:  Wasiliki Dedes; Livia Faes; Isaak Schipper; Lucas M Bachmann; Michael A Thiel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-22       Impact factor: 3.117

3.  Combined phototherapeutic keratectomy and therapeutic contact lens for recurrent erosions in bullous keratopathy.

Authors:  P Y Lin; C C Wu; S M Lee
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

4.  Alcohol delamination of the corneal epithelium for recalcitrant recurrent corneal erosion syndrome: a prospective study of efficacy and safety.

Authors:  Ravinder P Singh; Dev Raj; Anupama Pherwani; Ruby Lagnado; Asiya Abedin; Habibullah Eatamadi; Manu Mathew; Harminder S Dua
Journal:  Br J Ophthalmol       Date:  2007-02-14       Impact factor: 4.638

5.  [Recurrent corneal erosion. Different treatment options with the excimer laser with emphasis on aggressive PTK].

Authors:  P Eschstruth; W Sekundo
Journal:  Ophthalmologe       Date:  2006-07       Impact factor: 1.059

6.  Excimer laser phototherapeutic keratectomy in eyes with anterior corneal dystrophies: preoperative and postoperative ultrasound biomicroscopic examination and short-term clinical outcomes with and without an antihyperopia treatment.

Authors:  Christopher J Rapuano
Journal:  Trans Am Ophthalmol Soc       Date:  2003

7.  Clinical outcomes and time to recurrence of phototherapeutic keratectomy in Japan.

Authors:  Osamu Hieda; Satoshi Kawasaki; Kiyoshi Yamamura; Mina Nakatsukasa; Shigeru Kinoshita; Chie Sotozono
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

8.  Phototherapeutic keratectomy: Indications, methods and decision making.

Authors:  Rashmi Deshmukh; Jagadesh C Reddy; Christopher J Rapuano; Pravin K Vaddavalli
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.